Champions Oncology
Stock Forecast, Prediction & Price Target

Champions Oncology Financial Estimates

Champions Oncology Revenue Estimates

Champions Oncology EBITDA Estimates

Champions Oncology Earnings per Share Estimates

Passed Analyst forecast
Metric 4/30/2022 4/30/2023 4/30/2024 4/30/2026 4/30/2027
Revenue
 
% change YoY
$49.10M
 
N/A
$53.87M
 
9.69%
$50.15M
 
-6.89%
Avg: $59.31M
Low: $59.31M
High: $59.31M
avg. 18.25%
Avg: $66.72M
Low: $66.72M
High: $66.72M
avg. 12.50%
Net Income
 
% change YoY
$548K
 
N/A
$-5.33M
 
-1073.54%
$-7.27M
 
-36.38%
Avg: $677.07K
Low: $677.07K
High: $677.07K
avg. 109.30%
Avg: $0
Low: $0
High: $0
avg. -100%
EBITDA
 
% change YoY
$2.23M
 
N/A
$-2.06M
 
-192.61%
$-5.05M
 
-144.27%
Avg: $942.31K
Low: $942.31K
High: $942.31K
avg. 118.64%
Avg: $1.06M
Low: $1.06M
High: $1.06M
avg. 12.50%
EPS
 
% change YoY
$0.04
 
N/A
-$0.39
 
-1039.75%
-$0.54
 
-38.46%
Avg: $0.05
Low: $0.05
High: $0.05
avg. 109.25%
Avg: $0
Low: $0
High: $0
avg. -100%
Operating Expenses
 
% change YoY
$24.87M
 
N/A
$28.78M
 
15.74%
$28.11M
 
-2.35%
Avg: $18.41M
Low: $18.41M
High: $18.41M
avg. -34.48%
Avg: $20.71M
Low: $20.71M
High: $20.71M
avg. 12.50%

FAQ

What is Champions Oncology stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 54.65% in 2026-2027.

We have gathered data from N/A analysts. Their low estimate is 677.07K, average is 677.07K and high is 677.07K.

What is Champions Oncology stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 15.37% in 2026-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $59.31M, average is $59.31M and high is $59.31M.

What is Champions Oncology stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 54.62% in 2026-2027.

We have gathered data from N/A analysts. Their low earnings per share estimate is $0.05, average is $0.05 and high is $0.05.